Pasar al contenido principal

Refine your results

Filtros
Buscar
Include spaces in matter number if applicable. Ex.: 182 3125
Fecha
Displaying 14141 - 14160 of 44620
Cases and Proceedings
Commissioner Statements

Dissenting Statement of Commissioner Joshua D. Wright - In the Matter of Fidelity National Financial, Inc. and Lender Processing Services, Inc.

… Dissenting Statement of Commissioner Joshua D. Wright - In the Matter of Fidelity National Financial, Inc. and …
Date
By
Joshua D. Wright, Ex Comisionado
Early Termination Notices

20130985: Gannett Co., Inc.; Belo Corp.

… 20130985: Gannett Co., Inc.; Belo Corp. HSR Early Termination Notice 20130985: Gannett Co., Inc.; Belo Corp. 20130985 Belo Corp. Belo Corp. Gannett Co., …
Date
Acquiring Party
Gannett Co., Inc.
Acquired Party
Belo Corp.
Acquired Entities
Belo Corp.
Early Termination Notices

20140312: AT&T Inc.; SoftBank Corporation

… 20140312: AT&T Inc.; SoftBank Corporation HSR Early Termination Notice 20140312: AT&T Inc.; SoftBank Corporation 20140312 Sprint Spectrum L.P. …
Date
Acquiring Party
AT&T Inc.
Acquired Party
SoftBank Corporation
Acquired Entities
Sprint Spectrum L.P.
Horizon Personal Communications, Inc.
Sprintcom, Inc.
Sprint PCS License, LLC
WirelessCo, L.P.
Early Termination Notices

20140313: SoftBank Corporation; AT&T Inc.

… 20140313: SoftBank Corporation; AT&T Inc. HSR Early Termination Notice 20140313: SoftBank Corporation; AT&T Inc. 20140313 New Cingular Wireless PCS, LLC Missouri RSA …
Date
Acquiring Party
SoftBank Corporation
Acquired Party
AT&T Inc.
Acquired Entities
New Cingular Wireless PCS, LLC
Missouri RSA 11/12 L.P.
Missouri RSA 8 L.P.
Early Termination Notices

20140314: Comvest Investment Partners IV, L.P.; Amin Rahman Ramjee

… 20140314: Comvest Investment Partners IV, L.P.; Amin Rahman Ramjee HSR Early Termination Notice 20140314: … Partners IV, L.P.; Amin Rahman Ramjee 20140314 Bel USA LLC Amin Rahman Ramjee Comvest Investment Partners IV, …
Date
Acquiring Party
Comvest Investment Partners IV, L.P.
Acquired Party
Amin Rahman Ramjee
Acquired Entities
Bel USA LLC
HSR Informal Interpretations

1312007 Informal Interpretation

… 1312007 Informal Interpretation 1312007 Informal Interpretation From: (Redacted) Sent: Thursday, … January 2014, must one look to 2013 revenues? In some cases they may not be available. I know for item 5, or certain …
Date
Rule
802.51
We have never allowed any grace period for 802.51. The rule says "in its most recent fiscal year". It's different for size of person because the rule specifically says not more than 15 months old. For...
HSR Informal Interpretations

1312008 Informal Interpretation

… 1312008 Informal Interpretation 1312008 Informal Interpretation From: … probably a very easy question for you but I want to confirm the thinking. In this transaction: 1. Fund A, B and C will … LLC to acquire target. 2. Initially Fund A will have the right to 50% of the profits and assets. 3. At closing …
Date
Rule
801.2
We look at the primary acquisition (of Target) as preceding the backside acquisitions (members of Target acquiring interests in Holdco LLC). So Fund A still controls at the time the Target interests...
Cases and Proceedings

Mylan Inc., Agila Specialties Global Pte.Limited, Agila Specialties Private Limited, and Strides Arcolab Limited, In the Matter of

… Mylan Inc., Agila Specialties Global Pte.Limited, Agila … Specialties Private Limited, and Strides Arcolab Limited, In the Matter of Mylan Inc., Agila Specialties Global …

Under a settlement with th FTC, Mylan, Inc., and Agila Specialties Global Pte. Ltd and Agila Specialties Pvt. Ltd. (collectively, Agila)  divested 11 generic injectable drugs as a condition of allowing Mylan’s proposed acquisition of Agila from Strides Arcolab Ltd. (Strides). According to the complaint, in each of these 11 markets, Mylan and Agila are two of only a limited number of current or likely future competitors. The number of suppliers in generic pharmaceutical markets matters because prices generally decrease as the number of competing generic suppliers increases. In addition, the injectable generic products of concern are highly susceptible to supply disruptions caused by the inherent difficulties of producing sterile liquid drugs.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
131 0112
Docket Number
C-4413
Displaying 14141 - 14160 of 44620
Return to top